Skip to main content
eScholarship
Open Access Publications from the University of California

UCSF

UC San Francisco Electronic Theses and Dissertations bannerUCSF

CYTOKINE CANDIDATE GENES PREDICT THE DEVELOPMENT OF SECONDARY LYMPHEDEMA FOLLOWING BREAST CANCER SURGERY

  • Author(s): Leung, Geraldine
  • Advisor(s): Miaskowski, Christine;
  • Aouizerat, Bradley
  • et al.
Abstract

The purpose of this study was to determine if variations in pro- and anti-inflammatory cytokine genes were associated with lymphedema (LE) following breast cancer treatment. Breast cancer patients completed a number of self-report questionnaires. LE was evaluated using bioimpedance spectroscopy. Genotyping was done using a custom genotyping array. No differences were found between patients with (n = 155) and without LE (n = 387) for the majority of the demographic and clinical characteristics. Patients with LE had a significantly higher body mass index, more advanced disease and a higher number of lymph nodes removed. Genetic associations were identified for four three genes (i.e., interleukin (IL4) 4 (rs2227284), IL 10 (rs1518111) and nuclear kappa factor beta 2 (NFKB2 (rs1056890)) associated with inflammatory responses. These genetic associations suggest a role for a number of pro- and anti-inflammatory genes in the development of LE following breast cancer treatment.

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View